Experimental models of arthritis in which pathogenesis is dependent on TNF expression

[1]  G. Efimov,et al.  Methods for in vivo molecular imaging , 2012, Biochemistry (Moscow).

[2]  E. Choy.  Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. , 2012, Rheumatology.

[3]  George Kollias,et al.  Blockade of TNF-α rapidly inhibits pain responses in the central nervous system , 2011, Proceedings of the National Academy of Sciences.

[4]  G. Benard,et al.  Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. , 2010, Immunotherapy.

[5]  Ernest Choy,et al.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor , 2009, Rheumatology.

[6]  S. Nedospasov,et al.  Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. , 2008, Cytokine & growth factor reviews.

[7]  M. Hochberg,et al.  The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006 , 2008, Current medical research and opinion.

[8]  D. Shcherbo,et al.  Bright far-red fluorescent protein for whole-body imaging , 2007, Nature Methods.

[9]  B. Ryffel,et al.  Tumor necrosis factor is critical to control tuberculosis infection. , 2007, Microbes and infection.

[10]  P. Emery,et al.  The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. , 2006, Arthritis and rheumatism.

[11]  Richard O. Williams,et al.  Analysing the effect of novel therapies on cytokine expression in experimental arthritis , 2005, International journal of experimental pathology.

[12]  L. Tessarollo,et al.  Novel tumor necrosis factor‐knockout mice that lack Peyer's patches , 2005, European journal of immunology.

[13]  E. Choy,et al.  The consequences of rheumatoid arthritis: quality of life measures in the individual patient. , 2005, Clinical and experimental rheumatology.

[14]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[15]  P. Emery,et al.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. , 2004, The New England journal of medicine.

[16]  J. O'dell,et al.  Therapeutic strategies for rheumatoid arthritis. , 2004, The New England journal of medicine.

[17]  Kutty Selva Nandakumar,et al.  Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis , 2004, European journal of immunology.

[18]  Kutty Selva Nandakumar,et al.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. , 2003, The American journal of pathology.

[19]  E. Grant,et al.  Essential Role for the C5a Receptor in Regulating the Effector Phase of Synovial Infiltration and Joint Destruction in Experimental Arthritis , 2002, The Journal of experimental medicine.

[20]  J. Edwards,et al.  Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. , 2001, Rheumatology.

[21]  I. Wicks,et al.  Collagen‐induced arthritis in C57BL/6 (H‐2b) mice: new insights into an important disease model of rheumatoid arthritis , 2000, European journal of immunology.

[22]  L. Matis,et al.  A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis , 2000, The Journal of Immunology.

[23]  S. S. Lee,et al.  IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. , 2000, The Journal of rheumatology.

[24]  George Kollias,et al.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease , 1999, Annals of the rheumatic diseases.

[25]  Suk-Kyeong Lee,et al.  Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[26]  J. Sedgwick,et al.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.

[27]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[28]  R. Holmdahl,et al.  B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA) , 1998, Clinical and experimental immunology.

[29]  Edward F. Rosloniec,et al.  Collagen‐Induced Arthritis , 1996, Current protocols in immunology.

[30]  C. Dinarello,et al.  A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. , 1996, Journal of immunology.

[31]  L. Matis,et al.  Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Kollias,et al.  The type I interleukin‐1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF‐transgenic mice , 1995, European journal of immunology.

[33]  H. Colten.  Drawing a double-edged sword , 1994, Nature.

[34]  R. Tooms,et al.  A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritic subchondral bone: proposal for a two-compartment model of immune-mediated disease with implications for immunotherapeutic strategies. , 1994, Clinical immunology and immunopathology.

[35]  P. Wooley,et al.  Collagen arthritis--what can it teach us? , 1994, British journal of rheumatology.

[36]  R. Holmdahl,et al.  Germline‐Encoded IgG Antibodies Bind Mouse Cartilage In Vivo: Epitope‐ and Idiotype‐Specific Binding and Inhibition , 1994, Scandinavian journal of immunology.

[37]  D. Kioussis,et al.  Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. , 1993, Journal of immunology.

[38]  R. Jonsson,et al.  Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice , 1992, Clinical and experimental immunology.

[39]  A. Kang,et al.  Induction of arthritis with monoclonal antibodies to collagen. , 1992, Journal of immunology.

[40]  A. Abbas,et al.  Cellular and Molecular Immunology , 1991 .

[41]  C. Dinarello,et al.  Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. , 1990, Blood.

[42]  M. Goto,et al.  Specificity of antibodies to type II collagen in rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[43]  R. Holmdahl,et al.  Collagen induced arthritis as an experimental model for rheumatoid arthritis , 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[44]  A. Kang,et al.  Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. , 1983, Arthritis and rheumatism.

[45]  A. Hassell,et al.  Qualitative research in RA. , 2012, Rheumatology.

[46]  P. Tak,et al.  Collagen-induced arthritis in mice. , 2010, Methods in molecular biology.

[47]  M. Hochberg,et al.  The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. , 2008, Current medical research and opinion.

[48]  Richard O. Williams.  Collagen-induced arthritis in mice. , 2007, Methods in molecular medicine.

[49]  J. Ravetch,et al.  Divergent roles for Fc receptors and complement in vivo. , 1998, Annual review of immunology.

[50]  J. Seyer,et al.  Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. , 1995, Autoimmunity.

[51]  H. Colten.  Immunology. Drawing a double-edged sword. , 1994, Nature.

[52]  R. Jonsson,et al.  Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. , 1991, Autoimmunity.

[53]  M. Feldmann,et al.  Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.